'Will it make me less of a man?': Vasectomy in UAE remains a stigma, say doctors
Misconceptions tied to masculinity, reversibility, and sexual function have kept interest low — even as more men are quietly discussing it in online spaces and behind closed doors.
Take Karim (name withheld upon request), a 34-year-old Abu Dhabi resident who first explored the option in 2019. His inquiry at a local clinic was met with confusion.
'The receptionist told me, 'We don't do that here. It's illegal in the UAE,'' he recalled. 'But I knew it wasn't, I had already researched it online.'
Determined, Karim continued searching until he found a private provider offering a non-scalpel vasectomy. The entire procedure took less than 30 minutes and caused minimal discomfort. Yet, what lingered wasn't the physical pain — it was the stigma.
'Even the doctor asked me if my wife (had) agreed. I had to assure him it wasn't a midlife crisis," he said.
Karim explained that the decision was not impulsive — it was a deeply considered, mutual decision. 'My wife has a chronic medical condition that makes pregnancy risky. We both knew early on we didn't want to take that chance, and I didn't want her to go through years of hormonal birth control just because I was afraid of a simple procedure.'
Low awareness
Despite being proven as one of the most effective and affordable long-term contraception methods for men, vasectomy uptake in the Middle East remains limited.
A 2021 study published in Urology Annals revealed that only 13 per cent of men in a Middle Eastern sample had even heard of the procedure. Just 0.4 per cent had undergone the procedure. Researchers pointed to religious beliefs, social pressure, and poor public health awareness as key barriers.
'There are massive misconceptions,' said Dr Hossam Zeitoun, a consultant urologist based in Abu Dhabi. 'The most common fears are about impotence, testosterone loss, or being less of a man. None of these are true, but they're deeply ingrained.'
What a vasectomy really involves
A vasectomy is a minor operation that involves cutting or blocking the vas deferens — the tubes that carry sperm — thereby preventing pregnancy. The non-scalpel version, widely used today, requires just a small puncture rather than stitches, with patients typically recovering within 48 hours.
'It has no impact on hormones or sexual performance,' Dr Zeitoun emphasised. 'Men will still produce semen; it simply won't contain sperm. But many still don't understand that."
Financial and systemic barriers
Beyond misinformation and misconceptions, a lack of financial and institutional support also discourages men from considering the procedure. While the procedure is legally allowed in the UAE, it is rarely covered by private health insurance.
'Costs typically range from Dh4,000 to Dh10,000,' said Dr Mohammed Arif, a Dubai-based urologist. 'It's considered an elective procedure, so most patients end up paying out of pocket.'
Adding to the challenge is a lack of national education or public health campaigns promoting male sterilisation — unlike the global efforts around female contraceptives.
A conversation still behind closed doors
With little open dialogue in mainstream settings in the UAE, many men — especially expats — turn to anonymous platforms like Reddit or private Facebook groups to seek information or anonymously share personal experiences.
'Some patients come in already informed, others ask things like 'Will I lose my sex drive?' or 'Will people know?'' said Dr Arif. 'That shows you how private and misunderstood this still is.'
Karim said that even now, he hasn't told most of his family or friends about the procedure. 'We didn't want kids, and that's our decision. But I don't want to spend time explaining that I'm not broken or selfish. It's just personal.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
6 hours ago
- The National
Abu Dhabi hospital reveals new brain scan to detect Alzheimer's earlier
A scan that can detect Alzheimer's disease before memory loss begins is now available in the UAE for the first time. The amyloid PET scan, recently launched at Cleveland Clinic Abu Dhabi, is a milestone in the region's fight against neurodegenerative diseases and paves the way for treatment in patients as young as 40. The advanced diagnostic tool reveals the accumulation of amyloid plaque in the brain. These masses of protein collect on the brain and they are seen as indicators of looming Alzheimer's. Crucially, they appear long before symptoms become apparent, meaning treatment can be administered at an earlier stage, which in turn makes the treatment more effective. "Traditional imaging like MRI or CT scans cannot detect amyloid plaque," Dr Hanan Sheikh Ibrahim, staff physician at the hospital's Neurological Institute, told The National. "This scan, however, can reveal the core pathology and determine if the patient is amyloid-positive. That informs not only the diagnosis, but the treatment. "If the scan is positive, we know the patient is likely to benefit from the latest plaque-targeting drugs such as donanemab or lecanemab. If the scan is negative, we can rule out Alzheimer's and look for reversible causes – like vitamin deficiencies, thyroid issues, sleep disorders, or even seizures." Using the science The launch of the scan follows the roll-out of a blood-based biomarker test, announced earlier this year at Abu Dhabi Health Week, which can also predict whether a person is likely to develop Alzheimer's in the future. When combined, the two tools allow for precision diagnosis and offer patients the opportunity to begin treatment or lifestyle interventions early. The scan is used to diagnose mild cognitive impairment (MCI), an early stage of cognitive decline. It can also help distinguish Alzheimer's from other forms of dementia such as vascular dementia, frontotemporal dementia, or dementia with Lewy bodies – conditions that can sometimes have overlapping or misleading symptoms. Earlier is better 'Alzheimer's can begin 20 years before symptoms appear,' Dr Ibrahim said. 'If we see plaque in someone in their 40s, we can start modifying their risk factors like controlling diabetes, treating sleep apnoea, or improving vascular health. The goal is to delay or even prevent dementia.' This new approach is a stark contrast to previous decades, when a diagnosis of Alzheimer's was considered the equivalent of a death sentence. "In the past, disclosing Alzheimer's felt like telling someone they had metastatic cancer," Dr Ibrahim said. "There was no treatment. Now, with better understanding and better tools, we can manage it. Alzheimer's is becoming more like diabetes – incurable but modifiable. We can slow it down. "We've also pioneered blood-based biomarkers in the UAE, which we've been using for the past two years. A blood test alone can sometimes predict Alzheimer's up to a decade in advance. Combined with the scan, we can offer a much more accurate and earlier diagnosis.' Who should get checked? Dr Ibrahim encourages individuals as young as 40 and especially those with high risk factors, to undergo screening. 'If you're in your mid-40s and have conditions like diabetes, hypertension, obesity, sleep apnoea, or a history of head trauma, you should get assessed,' she said. 'Also, if you're noticing symptoms or if loved ones are noticing changes – those are red flags.' Common early signs include: Increased forgetfulness or repeating questions Trouble with multitasking or decision-making Changes in mood, personality, or behaviour Mismanaging finances or getting lost while driving Decline in cooking skills or personal hygiene 'If loved ones are concerned, you should be concerned,' she said. 'In fact, we have screening questionnaires we give to spouses or daughters, who are often the first to notice that something's not right.' Not all dementias are the same Dr Ibrahim also stressed the importance of differentiating between Alzheimer's and other types of dementia. 'Some forms, like frontotemporal dementia, cause severe behavioural issues, disinhibition, hallucinations, or personality changes. These can progress faster and are harder on families. Alzheimer's can be more manageable by comparison, especially when caught early. 'Vascular dementia, often caused by uncontrolled blood pressure or diabetes, can sometimes be reversed or slowed by managing those conditions. That's why getting the diagnosis right is essential. 'We've had patients who were thought to have dementia but actually had untreated seizures or sleep apnoea. Once those were treated, their cognition improved.' Setting a new standard Cleveland Clinic Abu Dhabi is now working with the Emirati Genome Project and other institutions to improve screening and research across the country. 'We are collaborating with other healthcare facilities to build a national dementia registry to better understand the landscape,' Dr Ibrahim said. 'Right now, I can't say whether we have more cases than other countries because my clinic is biased – I only see patients with memory issues. But we do have more risk factors such as diabetes, obesity, sleep disorders so we're certainly more vulnerable. 'With this technology, Abu Dhabi is setting a new standard for dementia care – not just regionally, but globally.'
Gulf Business
8 hours ago
- Gulf Business
EFG Hermes advises on $190m investment in Alameda Healthcare
Image credit: Suppled photo EFG Hermes, an EFG Holding company and the leading investment bank in the Middle East and North Africa, announced it has acted as the Sole M&A Financial Advisor on a landmark $190m minority stake investment in Alameda Healthcare, one of Egypt's top private healthcare providers. Read- The investment was led by Development Partners International (DPI) in partnership with a consortium of institutional investors and development finance institutions. Following the transaction, Dr Fahad Khater, Chairman of Alameda, will remain the majority shareholder. The deal, primarily structured as a capital increase, is pending regulatory approvals and is expected to close in Q3 2025. This marks the largest foreign direct investment in Egypt's healthcare sector to date, reinforcing investor confidence in Egypt's high-growth, resilient industries. The transaction will inject foreign currency into Egypt's banking system and support Alameda's expansion both locally and in the GCC markets. Strategic expansion supported by capital injection 'This is a proud moment for EFG Hermes as we continue to deliver on our promise to guide clients through transformational transactions,' said Maged El Ayouti, Co-Head of Investment Banking at EFG Hermes. 'Securing a $190m investment for one of the region's fastest-growing healthcare platforms reflects our strong advisory capabilities and deep market expertise.' Alameda, under Dr Khater's leadership, plans to use the proceeds to scale its hospital operations and increase clinical capacity. The funding will support expansion in Egypt, Saudi Arabia, the UAE, and other GCC countries, bolstering its position as a regional healthcare leader. El Ayouti added that the firm's advisory role in this transaction is part of a broader track record of M&A excellence. Over the past 18 months, EFG Hermes has advised on M&A deals worth more than $2.5bn. Since the start of 2025, the investment bank has closed four M&A transactions, along with seven DCM and seven ECM deals across Egypt, the UAE, Saudi Arabia, and Oman. The investment represents a key milestone in both Alameda's growth journey and EFG Hermes's continued dominance in regional capital markets.
Zawya
8 hours ago
- Zawya
Cleveland Clinic Abu Dhabi performs first robotic lung transplant in gulf region
Cleveland Clinic Abu Dhabi has made history by performing the Gulf region's first-ever robotic lung transplant, making it one of the five centres in the world to have performed this surgery. With this landmark complex surgery, two patients have now successfully undergone robotic lung transplants, marking a major milestone in the region's advanced surgical and organ transplant capabilities. Both patients had idiopathic pulmonary fibrosis (IPF) as well as secondary pulmonary hypertension, a progressive condition that gradually scars the lungs and makes breathing increasingly difficult. These surgeries were quite complex due to pulmonary hypertension, a condition that puts extra strain on the heart and lungs. To support the patients during the operation, the medical team used Veno-Arterial ECMO, a technique that temporarily takes over the work of the heart and lungs while the damaged lungs are replaced. These life-saving surgeries would not have been possible without the extraordinary generosity of organ donor families, whose selfless gifts make such transplants possible. The hospital also acknowledges the critical role played by healthcare professionals from donor hospitals, the National Programme for Organ Donation and Transplantation – HAYAT, the Department of Health- Abu Dhabi, and the National Centre at the Ministry of Health and Prevention (MOHAP). Further solidifying its leadership in regional transplant medicine, Cleveland Clinic Abu Dhabi has surpassed a significant milestone this year, completing over 60 lung transplants since the relaunch of the programme in 2022, establishing itself as the most advanced and active centre of its kind in the region. These cases exemplify the programme's potential and underscores Cleveland Clinic Abu Dhabi's emergence as a global referral hub for patients with end-stage lung disease, including complex conditions such as Chronic Obstructive Pulmonary Disease as well as Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, and Bronchiectasis.
